0001225208-25-004188.txt : 20250409 0001225208-25-004188.hdr.sgml : 20250409 20250409185419 ACCESSION NUMBER: 0001225208-25-004188 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250409 DATE AS OF CHANGE: 20250409 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Neville Everett CENTRAL INDEX KEY: 0001641142 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 25826176 MAIL ADDRESS: STREET 1: ONE EXPRESS WAY CITY: ST. LOUIS STATE: MO ZIP: 63121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Group CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Cigna Corp DATE OF NAME CHANGE: 20181221 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 3 1 doc3.xml X0206 3 2025-03-31 0 0001739940 Cigna Group CI 0001641142 Neville Everett 900 COTTAGE GROVE RD BLOOMFIELD CT 06002 1 See Remarks Common Stock, $.01 Par Value 3509.0000 D Employee Stock Option (Right to Buy) 227.0200 2023-03-01 2032-02-23 Common Stock, $.01 Par Value 3622.0000 D Employee Stock Option (Right to Buy) 294.6100 2024-03-01 2033-02-22 Common Stock, $.01 Par Value 4391.0000 D Employee Stock Option (Right to Buy) 305.8550 2026-03-01 2035-02-28 Common Stock, $.01 Par Value 6386.0000 D Employee Stock Option (Right to Buy) 336.4750 2025-03-01 2034-02-28 Common Stock, $.01 Par Value 6091.0000 D Phantom Stock Units 0.0000 Common Stock, $.01 Par Value 11728.9306 D This option is fully vested. This option was granted on February 22, 2023 and vests in three equal annual installments. The first two installments became exercisable on March 1, 2024 and March 1, 2025, and the last installment becomes exercisable on March 1, 2026. This option vests in three equal annual installments beginning March 1, 2026. This option was granted on February 28, 2024, and vests in three equal annual installments. The first installment became exercisable on March 1, 2025, and the next two installments become exercisable on March 1, 2026 and March 1, 2027. Phantom stock units are payable in cash in accordance with the terms of the Express Scripts, Inc. Executive Deferred Compensation Plan. The reporting person may transfer his interests in The Cigna Group stock fund into an alternative investment fund. Represents phantom stock units under The Cigna Group stock fund of the Express Scripts, Inc. Executive Deferred Compensation Plan. Each phantom stock unit is the economic equivalent of one share of The Cigna Group common stock and is to be settled in cash. EVP, Strategy and Business Development Exhibit List: EX-24 Power of Attorney poaneville.txt Tyler Gratton, attorney-in-fact 2025-04-09 EX-24 2 poaneville.txt POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that the undersigned, an Officer of The Cigna Group, a Delaware corporation ("Cigna"), hereby makes, designates, constitutes and appoints NICOLE S. JONES, KARI KNIGHT STEVENS, ANDREA NELSON, JILL STADELMAN, MATTHEW ARNOLD, ELISE RYAN and TYLER GRATTON, each acting individually, as the undersigned's true and lawful attorneys-in-fact and agents, with full power and authority to act in the undersigned's capacity as an Officer of The Cigna Group for and in the name, place and stead of the undersigned to execute and deliver: (A) in connection with the filing with the Securities and Exchange Commission pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended, of: (i) Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, Forms 144 in accordance with Rule 144 promulgated under the Securities Act of 1933 and any and all other documents related thereto (including, but not limited to, Seller's Representation Letters) and to take further action as they, or any of them, deem appropriate in connection with the foregoing. Such attorneys-in-fact and agents, or any of them, are also hereby granted full power and authority, on behalf of and in the name, place and stead of the undersigned, to execute and deliver any and all such other documents, and to take further action as they, or any of them, deem appropriate in connection with the foregoing. The powers and authorities granted herein to such attorneys-in-fact and agents, and each of them, also include the full right, power and authority to effect necessary or appropriate substitutions or revocations. The undersigned hereby ratifies, confirms, and adopts, as his or her own act and deed, all action lawfully taken by such attorneys-in-fact and agents, or any of them, or by their respective substitutes, pursuant to the powers and authorities herein granted. This Power of Attorney with respect to Forms 3, 4, 5 and 144 shall remain in full force and effect until:, the undersigned no longer has responsibilities relating to Section 16 of the Securities Exchange Act of 1934 or Rule 144 promulgated under the Securities Act of 1933 with respect to the undersigned's beneficial ownership of securities of The Cigna Group, unless earlier revoked by the undersigned in a signed writing to each such attorney in fact. /s/ Everett Neville April 3, 2025